MX387200B - Extracto de streptococcus uberis como agente inmunogénico. - Google Patents
Extracto de streptococcus uberis como agente inmunogénico.Info
- Publication number
- MX387200B MX387200B MX2018009048A MX2018009048A MX387200B MX 387200 B MX387200 B MX 387200B MX 2018009048 A MX2018009048 A MX 2018009048A MX 2018009048 A MX2018009048 A MX 2018009048A MX 387200 B MX387200 B MX 387200B
- Authority
- MX
- Mexico
- Prior art keywords
- relates
- immunogenic agent
- biofilm
- agent
- extract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cell Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382060 | 2016-02-15 | ||
| PCT/EP2017/053306 WO2017140683A2 (en) | 2016-02-15 | 2017-02-14 | Streptococcus uberis extract as an immunogenic agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018009048A MX2018009048A (es) | 2019-03-28 |
| MX387200B true MX387200B (es) | 2025-03-18 |
Family
ID=55646514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018009048A MX387200B (es) | 2016-02-15 | 2017-02-14 | Extracto de streptococcus uberis como agente inmunogénico. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10946085B2 (https=) |
| EP (1) | EP3417049B1 (https=) |
| JP (1) | JP6839199B2 (https=) |
| KR (1) | KR102824686B1 (https=) |
| AU (1) | AU2017220528A1 (https=) |
| CA (1) | CA3012419A1 (https=) |
| ES (1) | ES2960326T3 (https=) |
| MX (1) | MX387200B (https=) |
| PL (1) | PL3417049T3 (https=) |
| WO (1) | WO2017140683A2 (https=) |
| ZA (1) | ZA201805039B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023048111A1 (ja) | 2021-09-21 | 2023-03-30 | 国立研究開発法人 農業・食品産業技術総合研究機構 | 無莢膜株を抗原として含むワクチン |
| EP4570265A1 (en) | 2023-12-15 | 2025-06-18 | Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. | Vaccine for use in preventing inflammatory conditions in cows |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60243024A (ja) * | 1983-12-29 | 1985-12-03 | Kitasato Inst:The | ストレプトコツカス・サンギス感染症予防用ワクチン,診断用抗原および抗体 |
| CA2059693C (en) * | 1991-01-28 | 2003-08-19 | Peter J. Kniskern | Polysaccharide antigens from streptococcus pneumoniae |
| CA2222701C (en) | 1995-06-08 | 2012-02-07 | University Of Saskatchewan | Camp factor of streptococcus uberis |
| ES2273861T3 (es) | 2000-06-12 | 2007-05-16 | University Of Saskatchewan | Inmunizacion de ganado vacuno lechero con proteina gapc frente a infecciones por streptococcus. |
| US20070231335A1 (en) * | 2005-07-20 | 2007-10-04 | Bruce Beutler | Compositions and methods for treating Gram positive bacterial infection in a mammalian subject |
| PT2468300T (pt) | 2006-09-26 | 2018-01-30 | Infectious Disease Res Inst | Composição para vacina contendo adjuvante sintético |
| WO2008098172A1 (en) * | 2007-02-09 | 2008-08-14 | Montana State University | Enhancement of innate resistance to infection |
| GB0818231D0 (en) | 2008-10-06 | 2008-11-12 | Univ Nottingham | Composition |
| BRPI1011753B8 (pt) * | 2009-06-22 | 2021-05-25 | Wyeth Llc | conjugados imunogênicos de polissacarídeo capsular de staphylococcus aureus de sorotipos 5 e 8, seu uso e composições que os compreendem |
| EP2680860A4 (en) | 2011-03-03 | 2014-08-20 | Univ Alberta | USE OF BACTERIAL ENDOTOXINES AND LIPOTEIC ACIDS FOR IMPROVED POSTPARTAL HEALTH AND PRODUCTIVITY OF MILK COWS AND THEIR NEWBORN |
| WO2012152898A1 (en) | 2011-05-12 | 2012-11-15 | Intervet International B.V. | Treatment of mastitis |
| BR112013032675A2 (pt) * | 2011-06-19 | 2017-08-08 | Vaxine Pty Ltd | composição adjuvante de vacina compreendendo partículas de inulina |
| KR101943171B1 (ko) | 2013-09-19 | 2019-01-29 | 조에티스 서비시즈 엘엘씨 | 유성 아쥬반트 |
-
2017
- 2017-02-14 PL PL17704038.3T patent/PL3417049T3/pl unknown
- 2017-02-14 AU AU2017220528A patent/AU2017220528A1/en not_active Abandoned
- 2017-02-14 EP EP17704038.3A patent/EP3417049B1/en active Active
- 2017-02-14 MX MX2018009048A patent/MX387200B/es unknown
- 2017-02-14 JP JP2018538841A patent/JP6839199B2/ja active Active
- 2017-02-14 CA CA3012419A patent/CA3012419A1/en active Pending
- 2017-02-14 ES ES17704038T patent/ES2960326T3/es active Active
- 2017-02-14 KR KR1020187021575A patent/KR102824686B1/ko active Active
- 2017-02-14 WO PCT/EP2017/053306 patent/WO2017140683A2/en not_active Ceased
- 2017-02-14 US US16/075,092 patent/US10946085B2/en active Active
-
2018
- 2018-07-26 ZA ZA2018/05039A patent/ZA201805039B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20190038736A1 (en) | 2019-02-07 |
| US10946085B2 (en) | 2021-03-16 |
| WO2017140683A3 (en) | 2017-10-12 |
| ES2960326T3 (es) | 2024-03-04 |
| CA3012419A1 (en) | 2017-08-24 |
| WO2017140683A2 (en) | 2017-08-24 |
| EP3417049B1 (en) | 2023-08-16 |
| JP2019504623A (ja) | 2019-02-21 |
| AU2017220528A1 (en) | 2018-08-09 |
| KR20180108619A (ko) | 2018-10-04 |
| ZA201805039B (en) | 2020-05-27 |
| JP6839199B2 (ja) | 2021-03-03 |
| BR112018015255A2 (pt) | 2018-12-18 |
| MX2018009048A (es) | 2019-03-28 |
| KR102824686B1 (ko) | 2025-06-25 |
| EP3417049A2 (en) | 2018-12-26 |
| PL3417049T3 (pl) | 2024-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20210109B1 (ar) | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك | |
| BR112018068593A2 (pt) | composições tópicas não aquosas que compreendem uma salicilanilida halogenada | |
| EP4631970A3 (en) | Nucleic acid molecules and uses thereof | |
| MX2017009308A (es) | Composiciones inmunogenicas para usar en vacunas neumococicas. | |
| NZ759686A (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| MX2017015881A (es) | Formulaciones para vacunas contra la neoplasia y metodos para preparar las mismas. | |
| EA201890747A1 (ru) | Способы лечения воспалительных заболеваний | |
| EA201500054A1 (ru) | Аттенуированные вакцины против streptococcus suis и способы их получения и применения | |
| PH12016501988A1 (en) | Antibacterial compounds | |
| MX381211B (es) | Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia. | |
| BR112016023613A2 (pt) | novo bacteriófago e composição compreendendo o mesmo | |
| TN2016000435A1 (en) | Novel macrocyclic compounds. | |
| MX378266B (es) | Inhibidores de gingipaina de lisina. | |
| BR112018015367A2 (pt) | carreadores oromucosais de nanofibra para tratamento terapêutico | |
| MX389771B (es) | Compuestos de minociclina para biodefensas. | |
| BR112016024096A2 (pt) | novo bacteriófago e composição compreendendo o mesmo | |
| ZA202203363B (en) | Immunogenic compositions | |
| CL2019001649A1 (es) | Método para el control de enfermedades bacterianas de plantas utilizando derivados de carboxamida. | |
| MX387200B (es) | Extracto de streptococcus uberis como agente inmunogénico. | |
| BR112016029619A2 (pt) | novas fluoroquinolonas e sesu usos no tratamento de infecções bacterianas | |
| MX394066B (es) | Nuevos compuestos | |
| BR112016030728A2 (pt) | método para tratar ou prevenir uma inflamação induzida por bactérias em um indivíduo, composição imunogênica, composição farmacêutica, uso da composição imunogênica, método para produzir uma composição imunogênica, e, método para tratar ou prevenir uma doença | |
| MX387201B (es) | Composiciones para el tratamiento contra infecciones. | |
| BR112018012033A2 (pt) | composição imunogênica e método para detectar infecção por h. pylori em um sujeito | |
| BR112016009076A2 (pt) | Composição, processos para preparar um compósito de fluoreto de cálcio e uma composição imunogênica, e, métodos para tratamento ou prevenção de uma infecção ou uma doença causada por vírus, bactéria ou parasita e para induzir uma resposta imunogênica em um humano |